- Conference
- November 2020
-
€2088EUR$2,486USD£1,799GBP
From €7172EUR$8,250USD£6,395GBP
- Report
- July 2020
- 287 Pages
From €4347EUR$5,000USD£3,876GBP
- Report
- June 2020
- 172 Pages
From €3608EUR$4,150USD£3,217GBP
- Report
- May 2020
- 93 Pages
From €4303EUR$4,950USD£3,837GBP
- Report
- May 2020
- 300 Pages
From €3038EUR$3,495USD£2,709GBP
- Report
- April 2020
- 71 Pages
From €5216EUR$6,000USD£4,651GBP
- Report
- March 2020
- 228 Pages
From €4303EUR$4,950USD£3,837GBP
- Report
- October 2019
- 31 Pages
From €2608EUR$3,000USD£2,325GBP
- Report
- October 2019
- 214 Pages
From €4347EUR$5,000USD£3,876GBP
From €6520EUR$7,500USD£5,814GBP
From €6520EUR$7,500USD£5,814GBP
From €6520EUR$7,500USD£5,814GBP
- Report
- July 2020
- 150 Pages
From €3982EUR$4,580USD£3,550GBP
- Report
- July 2020
- 135 Pages
From €3912EUR$4,500USD£3,488GBP
From €6520EUR$7,500USD£5,814GBP
From €6520EUR$7,500USD£5,814GBP
From €6520EUR$7,500USD£5,814GBP
From €6520EUR$7,500USD£5,814GBP
From €6520EUR$7,500USD£5,814GBP

A core activity in so many areas like medicine, life science, pharmaceuticals – in clinical, industrial and research settings – in vitro diagnostics (IVD) is a major market with big technological and commercial prospects and is forecast to grow at a CAGR of 6.55 percent over the period 2011-2015. The main growth drivers are the increasing demand for biomarker-based tests worldwide and an increased adoption of DNA probe-based diagnostics.
Our wealth of detailed and insightful reports covers a wide variety of topics within the IVD sphere; these include immunochemistry, molecular diagnostics, point-of-care testing, microbiology, hematology, immunoassays and infectious immunology.
Make your move based on the latest knowledge and data in this dynamic field by keeping track of investment opportunities, scientific developments, new products and technologies, market shares, key players and much more.
Hundreds of companies operating in today’s market are featured in our publications, including top global players such as Abbott Laboratories, bioMerieux SA, Beckman Coulter, Becton Dickinson and Company, Hoffmann-La Roche, and Siemens Healthcare, as well as niche players and new, fast-growing companies. Show Less Read more